While established US biotech hubs may still rule the roost, emerging competitors are looking to grab a larger slice of the ...

EMD Serono has partnered the Trump administration to expand access to the company’s in vitro fertilisation (IVF) therapies.

France-based Adcytherix has completed a Series A funding round, raising €105m ($122m) earmarked for expediting the ADC ...

The AAM’s Giuseppe Randazzo warns that the generics business could become unsustainable in the future if the market dynamics ...

With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ...

Novo Nordisk will now run a Phase III trial for Omeros' former lead asset, zaltenibart in rare blood disorder, PNH.

Oceanpine Capital is to acquire an 80% equity stake in Beijing Jacoray Pharmaceutical Technology for 200m yuan ($28m).

Nabla Bio has entered a new multi-year research collaboration with Takeda to advance the AI-driven design of protein ...

The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen ...

Just a year after emerging from stealth with a nearly half a billion dollars, Kailera Therapeutics has reached another ...

"Meanwhile, Goldman Sachs led by value but faced close competition from JP Morgan. The investment banks had their own notable ...

PEGylation and glycosylation as bioconjugation tools for drug development: New webinar tackles complex chemistry for targeted ...